CLDN1 and hepatocellular carcinoma: It was observed that blocking CLDN-1 with cCPE variants in the Huh7.5 hepatoma cell line inhibited infection of Huh7.5 cells with HCV in a dose-dependent manner and this also opened the epidermal barrier in the reconstructed human epidermis [145].